[1] Damm K, et al. A highly selective telomerase inhibitor limiting human cell proliferation. EMBO J. 20(24): 6958-6968 (2001).
[2] PascoloE, et al. Mechanism of Human Telomerase Inhibition by BIBR1532, a Synthetic, Non-nucleosidic Drug Candidate. The Journal of Biological Chemistry 277: 15566-15572(2002).
[3] El-Daly H, et al. Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532. Blood 105(4): 1742-1749(2005).
[4] Röth A, et al. Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia. Leukemia. 21(12): 2456-2462 (2007).
[5] Meng E, et al. Targeted inhibition of telomerase activity combined with chemotherapy demonstrates synergy in eliminating ovarian cancer spheroid-forming cells. GynecolOncol. 124(3): 598-605 (2012).